Wed, Mar 20
|FDA White Oak Bldg 32
RAPID Working Group Meeting
Registry Assessment Of Peripheral Interventional Devices (RAPID) Working Group Meeting March 20, 2019: 7:45 am – 4:45 pm FDA Headquarters, White Oak Campus, Silver Spring, MD 20993 United States
Time & Location
Mar 20, 2019, 7:45 AM – 4:45 PM
FDA White Oak Bldg 32, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA
About the Event
Meeting Presentations:
RAPID PHASE II: OPC Results and Lessons Learned
Value, Resources, Next Steps, & Adjournment
RAPID: SFA-Popliteal Evidence Development (SPEED)
RAPID Phase III: GUDID Implementation Demonstration Project
Prospective Registry-based Trials Using VQI Sites: A RAPID Opportunity
Industry Perspective on Paclitaxel DCB and DES Evaluations
Challenges and Solutions when using Real World Evidence: Industry View
Overcoming Challenges – FDA Perspective
Leveraging the VISION CRN Infrastructure for Advanced Device Research and Surveillance
A Collaborative Data Sharing Construct for DCB Evaluations
Directions With Real World Evidence for Medical Devices
FDA Perspective On Prospective Registry Based Trials
Patient Level Data from Multiple Data Sources: RAPID Value to Industry
The methods for & results from SPEED will be posted upon publication of the manuscript
Email any questions to MDEpiNet_RAPID@dm.duke.edu